Abstract
Insulin is a hormone that regulates the physiological glucose level in human blood. Insulin injections are used to treat diabetic patients. The amyloid aggregation of insulin may cause problems during the production, storage, and delivery of insulin formulations. Several modifications to the C-terminus of the B chain have been suggested in order to improve the insulin formulation. The central fragments of the A and B chains (LYQLENY and LVEALYL) have recently been identified as β-sheet-forming regions, and their microcrystalline structures have been used to build a high-resolution amyloid fibril model of insulin. Here we report on a molecular dynamics (MD) study of single-layer oligomers of the full-length insulin which aimed to identify the structural elements that are important for amyloid stability, and to suggest single glycine mutants in the β-sheet region that may improve the formulation. Structural stability, aggregation behavior and the thermodynamics of association were studied for the wild-type and mutant aggregates. A comparison of the oligomers of different sizes revealed that adding strands enhances the internal stability of the wild-type aggregates. We call this “dynamic cooperativity”. The secondary structure content and clustering analysis of the MD trajectories show that the largest aggregates retain the fibril conformation, while the monomers and dimers lose their conformations. The degree of structural similarity between the oligomers in the simulation and the fibril conformation is proposed as a possible explanation for the experimentally observed shortening of the nucleation lag phase of insulin with oligomer seeding. Decomposing the free energy into electrostatic, van der Waals and solvation components demonstrated that electrostatic interactions contribute unfavorably to the binding, while the van der Waals and especially solvation effects are favorable for it. A per-atom decomposition allowed us to identify the residues that contribute most to the binding free energy. Residues in the β-sheet regions of chains A and B were found to be the key residues as they provided the largest favorable contributions to single-layer association. The positive ∆∆G mut values of 37.3 to 1.4 kcal mol−1 of the mutants in the β-sheet region indicate that they have a lower tendency to aggregate than the wild type. The information obtained by identifying the parts of insulin molecules that are crucial to aggregate formation and stability can be used to design new analogs that can better control the blood glucose level. The results of our simulation may help in the rational design of new insulin analogs with a decreased propensity for self-association, thus avoiding injection amyloidosis. They may also be used to design new fast-acting and delayed-release insulin formulations.
Similar content being viewed by others
References
Zierath JR, Krook A, Wallberg-Henriksson H (2000) Diabetologia 43:821–835
Shepherd PR, Kahn BB (1999) N Engl J Med 341:248–257
Nystrom FH, Quon MJ (1999) Cell Signal 11:563–574
Ottensmeyer FP, Beniac DR, Luo RZT, Yip CC (2000) Biochemistry 39:12103–12112. doi:10.1021/bi0015921
Wild S, Roglic G, Green A, Sicree R, King H (2004) Diabetes Care 27:1047–1053
Rewers M (2008) Diabetes Care 31:830–832. doi:10.2337/dc08-0245
Storkel S, Schneider HM, Muntefering H, Kashiwagi S (1983) Lab Invest 48:108–111
Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, Gilbey SG, Watkins PJ (1988) Diabetologia 31:158–161
Greenwald J, Riek R (2010) Structure 18:1244–1260. doi:10.1016/j.str.2010.08.009
Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJM, Westermark P (2010) Amyloid J Protein Fold Disord 17:101–104. doi:10.3109/13506129.2010.526812
Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E (1997) J Pharm Sci 86:517–525
Wilhelm KR, Yanamandra K, Gruden MA, Zamotin V, Malisauskas M, Casaite V, Darinskas A, Forsgren L, Morozova-Roche LA (2007) Eur J Neurol 14:327–334. doi:10.1111/j.1468-1331.2006.01667.x
Ahmad A, Uversky VN, Hong D, Fink AL (2005) J Biol Chem 280:42669–42675. doi:10.1074/jbc.M504298200
Ivanova MI, Sievers SA, Sawaya MR, Wall JS, Eisenberg D (2009) Proc Natl Acad Sci USA 106:18990–18995. doi:10.1073/pnas.0910080106
Groenning M, Frokjaer S, Vestergaard B (2009) Curr Protein Pept Sci 10:509–528
Sluzky V, Klibanov AM, Langer R (1992) Biotechnol Bioeng 40:895–903
Grillo AO, Edwards KLT, Kashi RS, Shipley KM, Hu L, Besman MJ, Middaugh CR (2001) Biochemistry 40:586–595
Onoue S, Ohshima K, Debari K, Koh K, Shioda S, Iwasa S, Kashimoto K, Yajima T (2004) Pharm Res 21:1274–1283
Valla V (2010) Exp Diabetes Res 14:178372. doi:10.1155/2010/178372
Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KPR, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W, Riek R (2009) Science 325:328–332. doi:10.1126/science.1173155
Maji SK, Schubert D, Rivier C, Lee S, Rivier JE, Riek R (2008) PLoS Biol 6:240–252. doi:10.1371/journal.pbio.0060017
Zhao F, Ma ML, Xu B (2009) Chem Soc Rev 38:883–891
Bell DSH (2007) Drugs 67:1813–1827
Geddes AJ, Parker KD, Atkins EDT, Beighton E (1968) J Mol Biol 32:343–344
Bouchard M, Zurdo J, Nettleton EJ, Dobson CM, Robinson CV (2000) Protein Sci 9:1960–1967
Burke MJ, Rougvie MA (1972) Biochemistry 11:2435–2439
Nettleton EJ, Tito P, Sunde M, Bouchard M, Dobson CM, Robinson CV (2000) Biophys J 79:1053–1065
Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, Madsen AO, Riekel C, Eisenberg D (2007) Nature 447:453–457. doi:10.1038/nature05695
Jimenez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, Saibil HR (2002) Proc Natl Acad Sci USA 99:9196–9201. doi:10.1073/pnas.142459399
Vestergaard B, Groenning M, Roessle M, Kastrup JS, van de Weert M, Flink JM, Frokjaer S, Gajhede M, Svergun DI (2007) PLoS Biol 5:1089–1097. doi:10.1371/journal.pbio.0050134
Choi JH, May BCH, Wille H, Cohen FE (2009) Biophys J 97:3187–3195. doi:10.1016/j.bpj.2009.09.042
Gibson TJ, Murphy RM (2006) Protein Sci 15:1133–1141. doi:10.1110/ps.051879606
Nielsen L, Frokjaer S, Brange J, Uversky VN, Fink AL (2001) Biochemistry 40:8397–8409
Brange J, Dodson GG, Edwards DJ, Holden PH, Whittingham JL (1997) Proteins 27:507–516
Devlin GL, Knowles TPJ, Squires A, McCammon MG, Gras SL, Nilsson MR, Robinson CV, Dobson CM, MacPhee CE (2006) J Mol Biol 360:497–509. doi:10.1016/j.jmb.2006.05.007
Hong DP, Fink AL (2005) Biochemistry 44:16701–16709. doi:10.1021/bi051658y
Ivanova MI, Thompson MJ, Eisenberg D (2006) Proc Natl Acad Sci USA 103:4079–4082. doi:10.1073/pnas.0511298103
Tito P, Nettleton EJ, Robinson CV (2000) J Mol Biol 303:267–278
Zheng J, Jang H, Ma B, Tsai CJ, Nussinov R (2007) Biophys J 93:3046–3057. doi:10.1529/biophysj.107.110700
Horn AHC, Sticht H (2010) J Phys Chem B 114:2219–2226. doi:10.1021/jp100023q
Tsai HH, Reches M, Tsai CJ, Gunasekaran K, Gazit E, Nussinov R (2005) Proc Natl Acad Sci USA 102:8174–8179
Mark AE, Berendsen HJC, Vangunsteren WF (1991) Biochemistry 30:10866–10872
Zoete V, Meuwly M, Karplus M (2004) Proteins Struct Funct Bioinf 55:568–581. doi:10.1002/prot.20071
Zoete V, Meuwly M (2006) J Comput Chem 27:1843–1857. doi:10.1002/jcc.20512
Zoete V, Meuwly M, Karplus M (2005) Proteins Struct Funct Bioinf 61:79–93. doi:10.1002/prot.20528
Falconi M, Cambria MT, Cambria A, Desideri A (2001) J Biomol Struct Dyn 18:761–772
Lu BZ, Chen WZ, Wang CX, Xu XJ (2002) Proteins 48:497–504. doi:10.1002/prot.10172
Sasahara K, Naiki H, Goto Y (2005) J Mol Biol 352:700–711. doi:10.1016/j.jmb.2005.07.033
Meersman F, Dobson CM (2006) BBA Proteins Proteomics 1764:452–460. doi:10.1016/j.bbapap.2005.10.021
Mayer JP, Zhang F, DiMarchi RD (2007) Biopolymers 88:687–713. doi:10.1002/bip.20734
Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Wang B, Hayik S, Roitberg A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2010) AMBER 11. University of California, San Francisco
Mauro M, Craparo EF, Podesta A, Bulone D, Carrotta R, Martorana V, Tiana G, San Biagio PL (2007) J Mol Biol 366:258–274. doi:10.1016/j.jmb.2006.11.008
Arora A, Ha C, Park CB (2004) Protein Sci 13:2429–2436. doi:10.1110/ps.04823504
Ryckaert JP, Ciccotti G, Berendsen HJC (1977) J Comput Phys 23:327–341
Humphrey W, Dalke A, Schulten K (1996) J Mol Graph 14:33–38
Jouaux EM, Timm BB, Arndt KM, Exner TE (2009) J Pept Sci 15:5–15. doi:10.1002/psc.1078
Wiltzius JJW, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, Eisenberg D (2008) Protein Sci 17:1467–1474. doi:10.1110/ps.036509.108
Kollman PA, Massova I, Reyes C, Kuhn B, Huo SH, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Acc Chem Res 33:889–897. doi:10.1021/ar000033j
Gohlke H, Case DA (2004) J Comput Chem 25:238–250. doi:10.1002/jcc.10379
Chong LT, Duan Y, Wang L, Massova I, Kollman PA (1999) Proc Natl Acad Sci USA 96:14330–14335
Massova I, Kollman PA (1999) J Am Chem Soc 121:8133–8143
Chong LT, Pitera JW, Swope WC, Pande VS (2009) J Mol Graph Model 27:978–982. doi:10.1016/j.jmgm.2008.12.006
Buchete NV, Hummer G (2007) Biophys J 92:3032–3039. doi:10.1529/biophysj.106.100404
Huet A, Derreumaux P (2006) Biophys J 91:3829–3840. doi:10.1526/biophysj.106.090993
Berhanu WM, Masunov AE (2010) Biophys Chem 149:12–21. doi:10.1016/j.bpc.2010.03.003
Berhanu WM, Masunov AE (2011) J Mol Model. doi:10.1007/s00894-010-0912-4
Kabsch W, Sander C (1983) Biopolymers 22:2577–2637
Keller B, Daura X, van Gunsteren WF (2010) J Chem Phys 132:16. doi:10.1063/1.3301140
Shao JY, Tanner SW, Thompson N, Cheatham TE (2007) J Chem Theor Comput 3:2312–2334. doi:10.1021/ct700119m
Takeda T, Klimov DK (2009) Biophys J 96:4428–4437. doi:10.1016/j.bpj.2009.03.015
Bhak G, Choe YJ, Paik SR (2009) BMB Rep 42:541–551
Harper JD, Lansbury PT (1997) Annu Rev Biochem 66:385–407
Soto C, Estrada L, Castilla J (2006) Trends Biochem Sci 31:150–155. doi:10.1016/j.tibs.2006.01.002
Padrick SB, Miranker AD (2002) Biochemistry 41:4694–4703. doi:10.1021/bi0160462
Ono K, Condron MM, Teplow DB (2009) Proc Natl Acad Sci USA 106:14745–14750. doi:10.1073/pnas.0905127106
Sorci M, Grassucci RA, Hahn I, Frank J, Belfort G (2009) Proteins 77:62–73. doi:10.1002/prot.22417
Heldt CL, Sorci M, Posada D, Hirsa A, Belfort G (2011) Biotechnol Bioeng 108:237–241. doi:10.1002/bit.22902
Nayak A, Lee CC, McRae GJ, Belfort G (2009) Biotechnol Prog 25:1508–1514. doi:10.1002/btpr.255
Nayak A, Sorci M, Krueger S, Belfort G (2009) Proteins 74:556–565. doi:10.1002/prot.22169
Manno M, Giacomazza D, Newman J, Martorana V, San Biagio PL (2010) Langmuir 26:1424–1426. doi:10.1021/la903340v
Fodera V, Cataldo S, Librizzi F, Pignataro B, Spiccia P, Leone M (2009) J Phys Chem B 113:10830–10837. doi:10.1021/jp810972y
Xue WF, Homans SW, Radford SE (2008) Proc Natl Acad Sci USA 105:8926–8931. doi:10.1073/pnas.0711664105
Fawzi NL, Okabe Y, Yap EH, Head-Gordon T (2007) J Mol Biol 365:535–550. doi:10.1016/j.jmb.2006.10.011
Fawzi NL, Kohlstedt KL, Okabe Y, Head-Gordon T (2008) Biophys J 94:2007–2016. doi:10.1529/biophysj.107.121467
Acknowledgments
This work was supported in part by the National Science Foundation (CCF/CHE 0832622). This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table 1S
Summary of the simulated single-layer insulin oligomer aggregate system (DOC 52 kb)
Table 2S
Clustering metric values for the wild-type clusters per system (DOC 62 kb)
Table 3S
Decomposition of the free energy on a per-residue basis for key residues in the monomer association of the single-layer ten-stranded insulin SH1-ST10. (A) Total Binding Free Energy Decomposition. (B) Decomposition of the contribution of the side chains to the binding free energy. (C) Decomposition of the contribution of the backbone to the binding free energy (DOC 110 kb)
Table 4S
Decomposition of the free energy on a per-residue basis for residues in chain A of the monomer association of the single-layer ten-stranded insulin SH1-ST10 and mutants of that insulin in chain A (DOC 150 kb)
Table 5S
Decomposition of the free energy on a per-residue basis for residues in chain A of the monomer association of the single-layer ten-stranded insulin SH1-ST10 and mutants of that insulin in chain B (DOC 251 kb)
Fig. S1
Secondary structural elements of the insulin model (initial structure). Helices are shown as magenta ribbons, β-strands as yellow arrows, and the rest are shown as loops. The positions of the disulfide bonds are indicated by a blue line (JPEG 110 kb)
Fig. S2
Superposition of the initial structures of single-layer insulin oligomer aggregates on the most representative structures of the most populated clusters (A SH1-ST1, B SH1-ST2, C SH1-ST4, D SH1-ST6, E SH1-ST4, and F SH1-ST6) for the corresponding aggregates. The initial structures are shown in blue and the most populated clusters with their corresponding cluster occupancies (in %) are shown in magenta (JPEG 127 kb)
Fig. S3
Profile of ∆∆G against the number of chains in single-layer insulin oligomer aggregate nucleation fibrillation. When the number of chains is high, the oligomer is stable and has favorable free energy (JPEG 44 kb)
Rights and permissions
About this article
Cite this article
Berhanu, W.M., Masunov, A.E. Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models. J Mol Model 18, 1129–1142 (2012). https://doi.org/10.1007/s00894-011-1123-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-011-1123-3